Discussions on Diversity
Listening and learning from patients and physicians about critical barriers to accessing clinical research and ways to overcome them.
Watch VideoListening and learning from patients and physicians about critical barriers to accessing clinical research and ways to overcome them.
Watch VideoThrough these series of reports, we will share feedback from both our quantitative and qualitative research sources to support greater understanding and highlight areas for action.
Discussion Chapters
Discussion on Diversity reports provide in-depth, expert insight from a range of seasoned professionals with extensive knowledge about life sciences, patient advocacy, life sciences, and diversity, equity, and inclusion in healthcare.
Rosamund Round:
The purposes of the report is to speak to people from these communities, understand the barriers, understand the challenges in regards to research, and get their feedback and their input about ways to overcome them. So actually working with people to listen, understand, do more and do better. And it's so important, I think, the world that we live in. We need to ensure that we are giving equitable access to people for clinical research, but also making sure that our study population is reflective of the patient population. Working with the communities, getting this information, we can then use that to build a roadmap for the particular services and tools that we need to build to work in different ways to be successful. So making sure that we're understanding, building tools, services, working with sites, working with patient communities, and then sharing that information openly. It's not just a Parexel piece. We want everyone to know. We want to support everybody, sponsors, even our competitors, to make sure that we're sharing this information and doing a much better job of being more inclusive.
Our Research Methods
Hosted semi-structured roundtables with Black, Latinx, Asian, transgender and non-binary members of Parexel’s Patient Advisory Councils in Australia, Germany, Italy, UK and US.
Held in-depth discussions with medical professionals across US and Canada.
Received input from 1,945 respondents across a broad range of racial and ethnic groups in Australia, Canada, France, Hungary, Italy, Mexico, Poland, Spain, UK and US.
Conducted interviews with Black, Latinx and Asian members of the UK and US public.
Conducted a series of scientific literature searches for articles published from January 2018 to July 2022 that specifically mentioned transgender or non-binary patients.
The contents of this report are the opinions of third parties derived from surveys, focus group sessions, interviews and patient advisory group meetings and do not reflect the opinions or positions of Parexel or its affiliates.